4-Oxo-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine-3-carboxylic acid

Catalog No.: 
ACFXIC632
CAS No.: 
1443978-46-8
Molecular Formula: 
C6H6N4O3
Molecular Weight: 
182.14
4-Oxo-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$272.00InquiryInquiry
100mg97%$395.00InquiryInquiry
250mg97%$557.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Oxo-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine-3-carboxylic acid
IUPAC Name4-oxo-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine-3-carboxylic acid
Molecular FormulaC6H6N4O3
Molecular Weight182.14
SMILESO=C(C1=C(N(N=N1)CCN2)C2=O)O
InChI KeyBILOQCAFTXQUIX-UHFFFAOYSA-N
Synonym4-Oxo-4,5,6,7-tetrahydro-[1,2,3]triazolo[1,5-a]pyrazine-3-carboxylic acid;[1,2,3]Triazolo[1,5-a]pyrazine-3-carboxylic acid, 4,5,6,7-tetrahydro-4-oxo-;4-Oxo-4H,5H,6H,7H-[1,2,3]triazolo[1,5-a]pyrazine-3-carboxylic acid
CAS No.1443978-46-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFXIC632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFXIC632 route product structure diagram
    ACFXIC6321443978-46-8
Inquiry

2. ACFXIC632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFXIC632 route product structure diagram
    ACFXIC6321443978-46-8
Inquiry

3. ACFXIC632 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFXIC632 route product structure diagram
    ACFXIC6321443978-46-8
Inquiry

Comments (0)